Fusheng Pharmaceutical surged more than 17% at the opening of the trading, reaching a high of $17.

Richluck Pharmaceutical rose over 17% in early trading, reaching a high of 17 yuan. On the news front, the company is expected to have a net profit of 52-75 million yuan in the first quarter, a year-on-year increase of 2222.67%-3250.01%, mainly due to the simultaneous rise in volume and price of VC and FEC.